XML 16 R2.htm IDEA: XBRL DOCUMENT v3.24.2
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 258,257 $ 229,902
Marketable securities 406,819 193,436
Total cash, cash equivalents, and marketable securities 665,076 423,338
Accounts receivable, net 165,723 300,173
Unbilled receivables, net 164,533 237,379
Other current assets 76,323 68,137
Total current assets 1,071,655 1,029,027
Long-term unbilled receivables, net 81,218 85,402
Goodwill 81,410 81,611
Other long-term assets 302,249 314,696
Total assets 1,536,532 1,510,736
Current liabilities:    
Accounts payable 16,682 11,290
Accrued expenses 44,875 39,941
Accrued compensation and related expenses 81,110 126,640
Deferred revenue 352,618 377,845
Convertible senior notes, net 500,604  
Other current liabilities 20,677 21,343
Total current liabilities 1,016,566 577,059
Long-term convertible senior notes, net 0 499,368
Long-term operating lease liabilities 70,202 66,901
Other long-term liabilities 14,362 13,570
Total liabilities 1,101,130 1,156,898
Commitments and contingencies (Note 15)
Stockholders’ equity:    
Preferred stock, 1,000 shares authorized; none issued 0 0
Common stock, 200,000 shares authorized; 85,369 and 83,840 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively 854 838
Additional paid-in capital 473,030 379,584
(Accumulated deficit) (14,216) (8,705)
Accumulated other comprehensive (loss) (24,266) (17,879)
Total stockholders’ equity 435,402 353,838
Total liabilities and stockholders’ equity $ 1,536,532 $ 1,510,736